"En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia
about
Photoreceptor inner segment ellipsoid band integrity on spectral domain optical coherence tomographyOCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR StudyMacular telangiectasia type 2 (MacTel) in a 34-year-old patient.Macular telangiectasia type 2.Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trialSWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF NEOVASCULAR MACULAR TELANGIECTASIA TYPE 2.Enface Thickness Mapping and Reflectance Imaging of Retinal Layers in Diabetic Retinopathy.The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasiaEnhanced Visualization of Subtle Outer Retinal Pathology by En Face Optical Coherence Tomography and Correlation with Multi-Modal Imaging.CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.ASSESSING PHOTORECEPTOR STRUCTURE ASSOCIATED WITH ELLIPSOID ZONE DISRUPTIONS VISUALIZED WITH OPTICAL COHERENCE TOMOGRAPHY.Alterations in Retinal Layer Thickness and Reflectance at Different Stages of Diabetic Retinopathy by En Face Optical Coherence TomographyPeripapillary Intrachoroidal Cavitation in Myopia Evaluated with Multimodal Imaging Comprising "En-Face" Technique.Risk factors in patients with macular telangiectasia 2A in an Asian population: A case-control study.Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2.Automated detection of photoreceptor disruption in mild diabetic retinopathy on volumetric optical coherence tomography.Quantitative analysis of photoreceptor layer reflectivity on en-face optical coherence tomography as an estimator of cone density.ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography.[Visual acuity in anti-VEGF therapy for AMD : Can specific characteristics in the SD-OCT help?]
P2860
Q27021797-AA2E8025-109C-43FF-B23E-F427AB53634AQ33920383-8964D09B-CD05-4F62-B019-1A6580831B4CQ34235600-BA7866BC-EE59-4D90-AA69-2C100A66E105Q34316044-DFAEA975-7429-43D9-A3BE-9F789508A0BBQ34454997-4E8E39BF-DCA0-45A9-A804-1A0FEE8FD454Q35803256-720A6725-A433-42BF-AF19-7C5A3353CC7BQ35877402-18C05D42-8670-4982-8F82-7FE6186F892DQ36164500-65CB8105-E889-4E85-A4A8-411634469083Q36222349-E221B7ED-34B3-4783-A5C1-744DEF665287Q36379980-4C15CE61-93C7-4713-AD34-5492896C8453Q36830639-98FA0F4F-CD21-4D4A-A9DD-A44421EE0092Q37142911-66308BFB-CC1D-47C0-8A99-49AD63B76B4AQ41957707-E57AE77F-B3DE-48E8-9E38-2D63E850DB20Q42367346-754F97F4-E3A0-4E95-9E5B-A3EDEB529F41Q45163071-AED99EC4-DAB2-40EF-AD6E-A9C1A25126CFQ47137147-0C381F24-CF5C-4880-9B2D-B5DEDF60D6BBQ47815942-D306019E-7938-4676-916B-B36B46A1E39FQ50168908-4DA7C034-DA06-444A-B619-E1A4709020C5Q50936858-32CF7AEF-4AF0-4D4B-ABAF-52C17C121D5AQ53068715-76F5F6EE-3A4B-4D16-A592-5929BD94E458
P2860
"En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
"En face" OCT imaging of the I ...... opathic macular telangiectasia
@ast
"En face" OCT imaging of the I ...... opathic macular telangiectasia
@en
type
label
"En face" OCT imaging of the I ...... opathic macular telangiectasia
@ast
"En face" OCT imaging of the I ...... opathic macular telangiectasia
@en
prefLabel
"En face" OCT imaging of the I ...... opathic macular telangiectasia
@ast
"En face" OCT imaging of the I ...... opathic macular telangiectasia
@en
P2093
P2860
P356
P1476
"En face" OCT imaging of the I ...... opathic macular telangiectasia
@en
P2093
Alan C Bird
Catherine Egan
Daniel Pauleikhoff
Ferenc B Sallo
Gary S Rubin
MacTel Study Group
Mark C Gillies
Traci E Clemons
Ute E K Wolf-Schnurrbusch
P2860
P304
P356
10.1167/IOVS.12-10580
P407
P577
2012-09-14T00:00:00Z